Related Experiment Video
Updated: Jul 13, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Intravascular Lithotripsy for Common Femoral Artery Occlusive Disease
Pablo Del Canto Peruyera1, Miriam Linares Sánchez1, Andrés Álvarez Salgado1
1Vascular and Endovascular Surgery Department. Cabueñes University Hospital, Gijón, Spain.
Insights
Intravascular lithotripsy (IVL) combined with drug-coated balloons is a safe and effective treatment for common femoral artery disease in patients with chronic limb-threatening ischemia. This approach shows promise as an alternative to open surgery.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Endovascular Therapy
Background:
- Chronic limb-threatening ischemia (CLTI) poses significant challenges in common femoral artery (CFA) treatment.
- Assessing novel endovascular techniques for CFA disease is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the safety and feasibility of intravascular lithotripsy (IVL) for treating atherosclerotic lesions in the common femoral artery (CFA).
- To assess the effectiveness of IVL as a standalone or adjunctive therapy in patients with CLTI.
Main Methods:
- A retrospective analysis of 15 patients with CLTI treated with IVL for CFA disease between September 2021 and April 2023.
- Standard procedure involved IVL followed by drug-coated balloon (DCB) angioplasty (Paclitaxel or Sirolimus).
- Primary endpoint: effectiveness of IVL; Secondary endpoints: major adverse events and target lesion revascularization.
Main Results:
- 100% technical success rate with a mean residual stenosis of 11.88% post-IVL.
- No need for scaffold placement in any patient.
- One major adverse event (renal function decline); 0% cumulative clinically driven target lesion revascularization at a mean follow-up of 14 months.
Conclusions:
- Intravascular lithotripsy (IVL) with adjunctive DCB angioplasty is a safe and feasible option for CFA treatment in CLTI patients.
- This endovascular approach demonstrates potentially lower morbidity and mortality compared to open surgery.
- Further long-term studies are warranted to confirm these promising early findings.
Background:
The aim of this study is to assess the safety and feasibility of intravascular lithotripsy (IVL) for the treatment of the common femoral artery (CFA).
Methods:
We analyzed patients who received IVL treatment for CFA from September 2021 to April 2023. All patients included presented with chronic limb-threatening ischemia. Standard procedure was IVL with adjunctive drug-coated balloon (DCB) angioplasty using either Paclitaxel or Sirolimus. Primary endpoint was to assess effectiveness of IVL for atherosclerotic common femoral lesions. Secondary endpoints include major adverse events and clinically driven target lesion revascularization.
Results:
A total of 15 patients were included in the study. All but 1 received IVL + DCB angioplasty. Technical success was 100% with a mean residual stenosis after IVL of 11.88% (standard deviation [SD] 6.8). No scaffolding was needed. Adjunctive DCB angioplasty was used in 14 patients, 4 of them with a Paclitaxel-coated balloon and Sirolimus-coated balloon in the other 10 patients. One major adverse event was registered due to worsening of renal function in a patient with previous chronic kidney disease. Three patients died during the postoperative period, and for the other 11 patients, the mean follow-up was 14 months (SD 5.68). Mean upgrade in Rutherford Class was 3.58 (SD 0.79) and cumulative clinically driven target lesion revascularization during follow-up was 0%.
Conclusions:
IVL with adjunctive DCB angioplasty is a safe and feasible technique for treating CFA in chronic limb-threatening ischemia patients, with lower morbidity and mortality rates compared with open surgical series described in the literature. This implies shorter hospital stay and a faster recovery. IVL may be a good alternative to open surgery, but these encouraging early results must be confirmed with long-term follow-up studies.
More Related Videos
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi VI: Surgical Management